- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/10 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 277/10
Total number of patents in this class: 51
10-year publication summary
1
|
3
|
1
|
3
|
0
|
0
|
2
|
2
|
4
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
University of Florida Research Foundation, Inc. | 4020 |
8 |
BASF SE | 20933 |
4 |
The Board of Trustees of the University of Illinois | 2688 |
3 |
Kyoto University | 2800 |
3 |
Glaxo Group Limited | 4071 |
2 |
Jawaharlal Nehru Centre for Advanced Scientific Research | 87 |
2 |
Flagship Pioneering Innovations VI, LLC. | 456 |
2 |
L'OREAL, Société Anonyme | 15488 |
1 |
Syngenta Participations AG | 1903 |
1 |
FUJIFILM Corporation | 29367 |
1 |
Michelin Recherche et Technique S.A. | 2167 |
1 |
Amira Pharmaceuticals, Inc. | 70 |
1 |
Epitech Group S.r.l. | 22 |
1 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2822 |
1 |
Institut Pasteur de Lille | 174 |
1 |
Mitsubishi Gas Chemical Company, Inc. | 3465 |
1 |
National University Corporation Hokkaido University | 1342 |
1 |
Scent Science International Inc. | 16 |
1 |
Shionogi & Co., Ltd. | 854 |
1 |
The United States of America as represented by the Department of Health and Human Services | 83 |
1 |
Other owners | 14 |